Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AcryMed looks for tissue repair partners:

This article was originally published in Clinica

Executive Summary

AcryMed is actively seeking corporate partners to develop two new composite woundcare materials. The Irvine, California-based privately owned biomaterials company is developing a hydrophilic polymer which incorporates a controlled-release antimicrobial. The company says that the material kills both gram positive and gram negative bacteria (including MRSA), spore formers and fungus. The material has shown increased healing and other benefits in both acute and chronic wound use. The second material is an oxygen-carrying hydrophilic foam for ischaemic tissue.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075685

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel